During the past decade, Agios Savvas Anticancer Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Agios Savvas Anticancer Hospital" #1 collaborator was "Janssen Pharmaceutica" with 1 trials as a collaborator and "Karyopharm Therapeutics Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Agios Savvas Anticancer Hospital" are "Chronic Hepatitis" (2 trials), "Hepatitis B" (2 trials), "Multiple Myeloma" (2 trials), "Chemotherapy-induced Thrombocytopenia" (1 trials) and "KRAS p, G12c Mutated /Advanced Metastatic NSCLC" (1 trials). Many other conditions were trialed in "Agios Savvas Anticancer Hospital" in a lesser frequency.

Most popular intervention types in "Agios Savvas Anticancer Hospital" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Adefovir" (2 trials), "Clevudine" (2 trials), "Lenalidomide" (2 trials), "5Fluorouracil" (1 trials) and "AMG 510" (1 trials). Other intervention names were less common.

The vast majority of trials in "Agios Savvas Anticancer Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Agios Savvas Anticancer Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Agios Savvas Anticancer Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Agios Savvas Anticancer Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".